Study of PDTC on Muscle Wasting of Cancer Cachexia

佴永军,江志伟,姚平,黎介寿
DOI: https://doi.org/10.13241/j.cnki.pmb.2013.06.046
2013-01-01
Abstract:Objective: To investigate the effect of pyrrolidine dithiocarbamate(PDTC) on muscle atrophy of C26 cachectic mice.Methods: Male BALB/c mice bearing C26 adenocarcinoma were severed as cancer cachexia model.Saline and three doses of PDTC(10,50 or 100 mg/kg) were given intraperitoneally from the 7th day after tumor inoculation to sacrifice.In the 16th day,the mice were killed,and the body weight,non-tumor body weight,gastrocnemius weight,activity of NF-κB in tumor tissue,and IL-6 levels of serum and tumor tissue were measured.Results: Significantly reduce of non-tumor body weight and gastrocnemius decomposition were observed in all tumor-bearing mice(P0.01).Furthermore,Tumor-bearing caused a significant increase of IL-6(P0.01) in serum and tumor tissues.Administration of PDTC significantly inhibited the NF-κB activation in tumor tissues,inhibited IL-6 synthesis of the tumor cells,and at-tenuated the non-tumor body weight and gastrocnemius muscle.There was negative correlation between IL-6 level and gastrocnemius muscle weight(r=-0.87,P0.01).Conclusion: PDTC can improve muscle wasting of cancer cachexia through inhibition of NF-κB acti-vation and IL-6 synthesis.
What problem does this paper attempt to address?